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A B S T R A C T
Objective: The objective of this study was to evaluate the burden of sexual- and injection drug use-
related infections in male prisoners in Karachi, Pakistan.
Methods: We administered a structured questionnaire in a cross-sectional survey of 365 randomly
selected imprisoned men. We analyzed blood for the human immunodeﬁciency virus (HIV), hepatitis B
virus (HBV), and hepatitis C virus (HCV) by ELISA, and for syphilis by rapid plasma reaginwith Treponema
pallidum hemagglutination assay conﬁrmation. Subjects with possible tuberculosis (World Health
Organization criteria) provided sputum samples for an acid-fast bacillus smear and culture.
Results: The prevalence of tuberculosis was 2.2% (95% CI 0.71–3.8%). Of 357 of the randomly selected
prisoners (eight refused to give blood), 2.0% (95% CI 0.6–3.4) were HIV-infected; syphilis was conﬁrmed
in 8.9% (95% CI 6.0–11.8%), HBV in 5.9% (95% CI 3.5–8.3%), and HCV in 15.2% (95% CI 11.7–18.8). By self-
report, 59.2% had used any illicit drugs, among whom 11.8% (95% CI 8.5–15.0) had injected drugs. The
median length of stay in the prison had been 3.2 (range 1–72) months.
Conclusions: All four infections were prevalent among the prisoners in Pakistan. Prisons are excellent
venues for infectious disease screening and intervention given the conditions of poverty and drug
addiction. Collaboration with community-based health providers is vital for post-discharge planning.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Prisons are incubators for infectious diseases, yet are readily
accessible for screening and intervention.1 They provide a high-
yield opportunity for early disease detection, intervention, and
treatment, which would beneﬁt not only prisoners and prison
employees, but also family members and the general population
due to the high turnover of prisoners.1,2 About 9.25 million people
are held in prisons worldwide, with 30 million inmates moving
from prison to the community and/or back again each year.3,4
Prisons are typically overcrowded, offer limited access to health
care, and harbor high rates of airborne and blood-borne diseases.1,5
Inmates often come from marginalized populations, such as
injecting drug users (IDUs) and persons with high-risk sexual
behaviors (including sex workers), who are already at an increased
risk for these infections.5
Available global data suggest a high prevalence and transmis-
sion of infectious diseases, such as tuberculosis (TB), human
immunodeﬁciency virus (HIV), syphilis, hepatitis B virus (HBV),* Corresponding author. Tel.: +1 615 322 9374; fax: +1 615 322 9400.
E-mail address: mominkazi@gmail.com (A.M. Kazi).
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doi:10.1016/j.ijid.2009.11.012and hepatitis C virus (HCV) in prisons.6–14 Yet few research studies
in Pakistan have focused on disease detection, treatment,
community links, health education, and prevention for prison
inmates.15,16 Pakistan is the eighthmost heavily burdened country
for TB cases in the world, with an estimated prevalence rate of 263
active cases per 100 000 in 2006.17 Around 181 new cases per
100 000 are estimated to be added each year to the existing pool of
TB-infected persons in Pakistan.17 HIV patients are especially
vulnerable to TB reactivation or acquisition. TB case rates are
thought to be high in Pakistani prisons, but few representative
surveys have been done.18–20
In 2003, an outbreak of HIV infection was reported among IDUs
in a prison in the city of Larkana in Sindh Province, Pakistan.21,22
Subsequently, there has been a sudden rise in the prevalence of HIV
among IDUs in other major cities. Pakistan’s largest city, Karachi, is
also located in Sindh Province where HIV seroprevalence in IDUs
rose from 0.4% in 2004 to 30% in 2007.22–24 In the Round III
integrated behavioral and biological surveillance report, 2008, HIV
prevalence for IDUs in Karachi was 23.1%.25 Similar trends have
been seen among IDUs in other major cities of Pakistan with
documented increases in IDU seroprevalence to 30% in Hyderabad
and 50% in Sargodha.24 HIV is now prevalent among commercialses. Published by Elsevier Ltd. All rights reserved.
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Hijras (traditional transvestites). HIV seroprevalence in 2007 was
1.8% among Hijras and 1.5% among other MSM according to
surveys conducted in 12 cities of Pakistan.24 An increase in
sexually transmitted disease (STD) prevalence was noted among
high-risk populations, especially IDUs, Hijras, and other male sex
workers in Karachi and Lahore in 2005.26,27 The prevalence of
hepatitis B and C viruses in the general and high-risk population,
especially among IDUs, is also increasing at an alarming rate.28,29
The number of opiate users in Pakistan was estimated to be 0.7%
(628 000) of the adult population in 2006; among these, 77% were
estimated to be heroin users (484 000) and approximately 14% of
heroin users were IDUs (125 000).30
The Sindh AIDS Control Program has developed service
delivery packages for prison inmates and drug users for the
prevention of HIV/AIDS in the major prisons of Sindh Province,
including District Jail Malir.31 However, there is no provision for
screening for TB, HIV, STDs, or hepatitis, nor are effective control
measures in place. The objective of our study was to assess the
prevalence and risk factors of TB,HIV/AIDS, syphilis, HBV, andHCV
among incarcerated men in Karachi, the ﬁrst such a systematic
study in Pakistan. We also sought to upgrade care within the
prison, as well as to bridge the divide between discharged
prisoners and community services.
2. Methods
2.1. Study site and population
We conducted a cross-sectional study in District Jail Malir,
Karachi, Pakistan from December 2007 to January 2008. This
facility is both a jail and a prison and it serves as the principal
incarceration venue for adult males with illicit drug allegations, as
well as for men accused of many other crimes. The maximum
capacity of District Jail Malir is 893, but there are typically around
3000 inmates.32 The study protocol was approved by the
Vanderbilt University Institutional Review Board (IRB; Nashville,
TN, USA) after a special review by the Ofﬁce of Human Research
Protection (OHRP; Washington, DC, USA) and the Bridge Con-
sultants Foundation IRB (Karachi, Pakistan).
2.2. Sampling methods, study design, and sample size
District Jail Malir consists of 26 barracks of varying sizes, plus a
hospital barrack; prisoner populations range from two to 265
inmates per barrack. We assumed that disease prevalence would
differ between prisoners placed in the hospital barrack and those in
the other barracks. Hence we randomly sampled inmates using
stratiﬁed sampling across two strata: the 26 non-hospital barracks
and the one hospital barrack. Sampling within the non-hospital
barracks stratum was done proportional to the number of inmates
in each barrack. The hospital barrack was smaller in prisoner
population than the average barrack and we sampled 50% of the
prisoners in the hospital to obtain more precise prevalence
estimates. A sample size of 350was needed to estimate prevalence
with no greater than a 5%margin of error for all diseases. Assuming
a<10% refusal rate, randomnumber tables were used for sampling
385 subjects.
2.3. Data collection (questionnaire)
Jail health care staff and the study team were trained in data
collection techniques, laboratory techniques, clinical diagnosis of
TB, and ethical considerations of privacy and conﬁdentiality. All
consenting participants were interviewed by study doctors using a
structured questionnaire on TB, HIV, syphilis, HBV, and HCVhistory, sociodemographic factors, and history of sexual behaviors,
drug use, and previous incarcerations.
2.4. Recruitment process and informed consent
A list containing each prisoner’s identity number and
corresponding barrack was received from the prison staff. Study
participants were selected according to our pre-generated
randomized number list. At the prison clinic, each selected
prisoner was assigned an interviewer who was not afﬁliated with
the prison and reviewed the consent form (many prisoners were
illiterate), insuring privacy. Prisoners had full authority to accept
or refuse to take part in the study; it was explained to each
participant that his acceptance or refusal to take part in the study
would not affect his incarceration or the possibility of parole. Only
after thewritten consentwas signed (all prisoners could sign their
names), was the questionnaire administered by the interviewing
physician.
2.5. Sputum collection for TB diagnosis
Sputum samples were collected from participants suspected of
having TB as per World Health Organization (WHO) screening
criteria: (1) clinical symptoms such as cough >2 weeks, sputum
production, and/or weight loss; (2) previous TB or treatment in the
past 5 years; (3) body mass index <20 kg/m2; and/or (4) known
HIV infection.33 Three sputum samples were collected from men
with any of these four criteria and examined using the Ziehl–
Neelsen carbol fuchsin (ZNCF) method, direct and concentrated
sputum smears, and smear cultures using Lowenstein–Jensen (LJ)
medium. We deﬁned a prisoner as positive for TB if they had acid-
fast bacilli on smear and culture conﬁrmation.
2.6. Serological testing
A 5ml blood sample was collected from willing participants for
HIV, syphilis,HBVandHCVdetermination. Specimenswere testedat
the Sindh Institute ofUrologyand Transplantation (SIUT) as follows:
syphilis by rapid plasma reagin (RPR, Randox, Crumlin, UK) with
Treponema pallidum hemagglutination assay (TPHA, Randox, Crum-
lin, UK) conﬁrmation; antibodies for HBV by hepatitis B surface
antigen (HBsAg) ELISA (AXSYM, Abbott, Chicago, IL, USA); and for
HCV antibodies by ELISA (AXYSM version 3.0, Abbott, Chicago, IL,
USA). HIV antibody tests were conducted at the Sindh AIDS Control
Program by HIV-1/2 ELISA (Enzygnost, Dade Behring, Marburg,
Germany or Vironostika, BioMe´rieux, Boxtel, the Netherlands).
Positive HIV cases were conﬁrmed by Western blot (Genlab
Diagnostic, Redwood City, CA, USA).
2.7. Care and intervention policy
Active TB cases were registered with the prison clinic for daily
TB treatment. Treatment was continued outside the prison if the
prisoner was released during treatment through an arrangement
with a local non-governmental organization that has continued
beyond the end of the study. HIV- and syphilis-positive cases were
registered with the prison voluntary counseling and testing center
and followed up by the Sindh AIDS Control Program. RPR-positive/
TPHA-positive cases were treated with benzathine penicillin in the
prison, while hepatitis cases were referred to clinics at the Dow
University of Health Sciences.
2.8. Statistical analysis
Stratum-speciﬁc and overall prevalence estimates of TB, HIV,
syphilis, HBV, and HCV were computed. The Wilson conﬁdence
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prevalence estimates; 95% CI using unbiased estimators of the
true variance for stratiﬁed simple random sampleswere calculated
for the overall prevalence estimates. The relationship between
sociodemographic variables and a positive screening test for HIV,
HBV, and/or HCV or a positive screening for syphilis were assessed
using multivariable logistic regression models.
3. Results
From December 2007 to January 2008, we approached 384
prisoners for enrollment in the study. Ninety-ﬁve percent (n = 365)
of approached prisoners provided informed consent, of whom 364
(99.7%) agreed to the interview and 357 (97.8%) agreed to a blood
test. One prisoner refusing the interview agreed to the blood test
(Figure 1).
3.1. Sociodemographic proﬁle
The median age of the respondents was 27 (range 18–81) years
and 50% (182) of the inmates were married (Table 1). No formal
educationwas reported by 43.8% (158/361), 20.8% (75/361) had no
more than primary school education, and 17.5% (63/361) had some
or all of amiddle school education. Themonthly income of inmatesFigure 1. Flow chart of the data collection pat the time of arrest was <US$83 for 39.2% (129/329), US$83–333
for 50.5% (166/329), and >US$333 for 10.3% (34/329). Of the
inmates, 43.4% (158/361) were from Karachi, 6.6% (24/361) from
Sindh Province excluding Karachi, 21.3% (77/361) from Punjab
Province, 13.5% (49/361) from the Northwest Frontier Province
(NWFP), 3.3% (12/361) from Baluchistan Province and 0.6% (2/361)
from Azad Kashmir (Table 1). Eleven percent were foreign
nationals from nine countries on three continents.
3.2. Sexual and drug histories
By self-report, 45.9% (166/362) of the participants had paid for
sex with a female, 24.7% (41/166) of whom had used a condom
during the last paid sex (Table 1); 21.3% (77/362) of the total
participants reported having paid for sex with a male, 9.1% (7/77)
of whom had used a condom during the last paid sex. Five percent
(19/362) of the respondents reported having received money or
drugs for sex at least once.
Almost 60% (215/363) of the participants gave a history of drug
use excluding alcohol, of whom 11.8% (50/215; 95% CI 8.5–15.0)
were IDUs. Of the IDUs, 46% (23/50) had shared a needle or syringe,
84% (42/50) had been previously incarcerated, and 48.0% (24/50)
had a history of a surgery. The median duration of any kind of drug
use was 7.3 (range <1–70) months and the median duration ofrocess in the District Jail Malir, Karachi.
Table 1
Sociodemographic proﬁle and sexual, drug, and infectious disease history of the
male prison population sample (N = 364)
Demographics
Age in years, median (range)
(N = 364)a
27 (18–81)
Length of prison stay in months,
median (range) (N = 361)b
3.2 (<1–72)
Region of origin (N = 362),b n (%)
Karachi 158 (43.6%)
Sindh (excluding Karachi) 24 (6.6%)
Punjab 77 (21.3%)
Baluchistan 12 (3.3%)
North West Frontier Province 49 (13.5%)
Azad Kashmir 2 (0.6%)
Foreignerc 40 (11.0%)
Prior prison term (N = 364) 150 (41.2%)
Marital status (N = 364)
Married 182 (50%)
Single 168 (46.2%)
Separated, divorced or widowed 14 (3.8%)
Educational level (N = 361)b
No formal education 158 (43.8%)
Some or all primary or middle 138 (38.2%)
Some or all post-middle school 64 (17.7%)
Islamic religious studies 1 (0.3%)
Monthly income equivalent
in US$d (N = 329)b
<83 129 (39.2%)
83–333 166 (50.5%)
>333 34 (10.3%)
Sexual historyb
Ever paid for sex with a
fe
male (N = 362)
166 (45.9%)
Condom use during last paid sex
with a female (n = 166)
41 (24.7%)
Ever paid for sex with a male (N = 362) 77 (21.3%)
Condom use during last paid
sex with a male (n = 77)
7 (9.1%)
Ever received money or
drugs for sex (N = 362)
19 (5.2%)
Drug history
Illicit drug use in past six months at the time of incarceration
(N = 363)
215 (59.2%)
Injection drug use, % of all drug
users (n = 215)
50 (23.3%)
Needle sharing, % of injecting
drug users (n = 50)
23 (46%)
Length of drug use (months),
median (range) (n = 214)
7.3 (<1–70)
Length of injection drug use (months),
median (range) (n = 49)
<1 (<1–12)
History of infectious diseases
Prior tuberculosis diagnosis (N = 364) 23 (6.3%)
History of tuberculosis exposure in
prisoners with prior diagnosis (n = 23)
8 (34.8%)
Ever tested for HIV (N = 242) 41 (16.9%)
Prior HIV diagnosis (n = 41) 1 (2.4%)
Prior syphilis diagnosis (N = 364) 26 (7.1%)
Prior hepatitis B/hepatitis
C diagnosise (N = 364)
16 (4.4%)
Prior knowledge of HIV/AIDS (N = 364) 242 (66.5%)
a One of 365 prisoners (0.3%) refused the questionnaire, but provided a blood
sample.
b Refusals to answer included: three for length of prison stay, two for region of
origin, three for education level, 35 for income, and two for sexual history.
c India (19), Afghanistan (1), Bangladesh (4), Iran (3), Ukraine (1), United Arab
Emirates (2), Myanmar (1), Uzbekistan (1), and Nigeria (8).
d January 2008 exchange rate of 60 Pakistani rupees per US$1.
e Prisoners could not distinguish hepatitis B from hepatitis C, referring to both as
‘hepatitis’.
Table 2
Prevalence of tuberculosis, HIV, syphilis, hepatitis B, and hepatitis C in the male
prison population sample (N = 357, eight prisoners refused to give blood)a
Disease n (%) 95% CI
Tuberculosis sputum culture-positive 7 (2.2%) 0.71–3.8%
Hospitalized inmates 0 (0%) 0–6.9%
Non-hospitalized inmates 7 (2.3%) 1.1–4.7%
HIV, dual-positive 7 (2.0%) 0.6–3.4%
Hospitalized inmates 1 (1.9%) 0.1–9.9%
Non-hospitalized inmates 6 (2.0%) 0.9–4.2%
Syphilis, TPHA-conﬁrmed 32 (8.9%) 6.0–11.8%
Hospitalized inmates 5 (9.4%) 4.1–20.3%
Non-hospitalized inmates 27 (8.9%) 6.2–12.6%
Hepatitis B virus, ELISA-positive 21 (5.9%) 3.5–8.3%
Hospitalized inmates 3 (5.7%) 1.9–15.4%
Non-hospitalized inmates 18 (5.9%) 3.8–9.2%
Hepatitis C virus, ELISA-positive 65 (15.2%) 11.7–18.8%
Hospitalized inmates 21 (39.6%) 27.6–53.1%
Non-hospitalized inmates 44 (14.5%) 11.0–18.9%
CI, conﬁdence interval; TPHA, Treponema pallidum hemagglutination assay.
a For tuberculosis, 52 hospitalized inmates and 302 non-hospitalized inmates;
for all others, 53 hospitalized inmates and 304 non-hospitalized inmates.
Table 3
Multivariable logistic regression model to identify independent predictors of HIV,
hepatitis B virus, or hepatitis C virus
Covariate ORb 95% CI p-Value
Age (years) 1.04 1.0–1.08 0.08
Marital status, singlea 0.44 0.16–1.2 0.09
Marital status, othera 0.42 0.06–3.12 0.39
Injection drug use 24.32 9.35–63.2 <0.001
Paid heterosexual intercourse 1.07 0.47–2.46 0.96
Paid homosexual intercourse 1.40 0.54–3.6 0.62
Sex for drugs 2.24 0.54–9.27 0.24
Blood transfusion 2.09 0.61–7.14 0.23
Surgery 2.41 1.05–5.54 0.03
Clean blade at barber 0.48 0.19–1.23 0.1
OR, odds ratio; CI, conﬁdence interval.
a Reference category is ‘marital status, married’.
b All odds ratios are adjusted for all other variables in the table.
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percent (280/364) of the study participants smoked cigarettes or
used tobacco products and 51.9% (189/364) had a history of alcohol
use.3.3. Risk factors for infection
Twenty-ﬁve percent (91/364) of study participants had a
tattoo on their skin, 20.6% (75/364) had body piercings, 39.4%
(143/363) reported having a prior surgical procedure, and 26.7%
(97/363) reported that their barbers did not use a new blade for a
hair cut or shave. The median length of stay in the District Jail
Malir had been 3.2 (range <1–72) months. Forty-one percent
(150/364) of the participants had been incarcerated prior to the
current incarceration.
3.4. Prevalence
The prevalence of active TB by sputum smear was 2.2% (95% CI
0.71–3.8%) (Table 2). HIV prevalence was 2.0% (95% CI 0.6–3.4%).
Syphilis was conﬁrmed in 8.9% (95% CI 6.0–11.8%), HBV (HBsAg) in
5.9% (95% CI 3.5–8.3%), and HCV (HCV antibodies) in 15.2% (95% CI
11.7–18.8%) of subjects.
3.5. Multivariable models
Multivariable logistic regression models elucidated the rela-
tionship between inmate characteristics and reported risk
behaviors and positive status for the blood-borne and/or sexually
transmitted infections studied. Two models were constructed, one
for blood- and needle-borne diseases (HIV, HBV, HCV) and one for
syphilis. For both models, the following covariates were included:
age, marital status, injection drug use, paid heterosexual inter-
Table 4
Multivariable logistic regression model to identify independent predictors of
syphilis
Covariate ORb 95% CI p-Value
Age (years) 1.00 0.96–1.05 0.92
Marital status, singlea 0.68 0.24–1.91 0.46
Marital status, othera 1.80 0.31–10.56 0.51
Injection drug use 0.66 0.21–2.03 0.45
Paid heterosexual intercourse 3.28 1.24–8.7 0.02
Paid homosexual intercourse 0.54 0.18–1.64 0.29
Sex for drugs 0.99 0.19–5.17 0.97
Blood transfusion 1.42 0.34–5.97 0.62
Surgery 0.80 0.32–1.98 0.61
Clean blade at barber 0.86 0.31–2.38 0.65
OR, odds ratio; CI, conﬁdence interval.
a Reference category is ‘marital status, married’.
b All odds ratios are adjusted for all other variables in the table.
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blood transfusion, past surgery, and reporting if the barber used a
clean blade. We did not construct a model for TB due to the
comparatively low event frequency.
Being an IDU (adjusted odds ratio (ORadj) 24.3; 95% CI 9.4–63.2;
p < 0.001) and a history of surgery (ORadj 2.4; 95% CI 1.1–5.5; p =
0.03) were associated with a higher risk of HIV, HBV and/or HCV
(Table 3). Paying for heterosexual intercourse was associated with
an increased risk of syphilis (ORadj 3.3; 95% CI 1.2–8.7; p = 0.02)
(Table 4). The prevalence of HCV showed the only signiﬁcant
association (hospital versus barracks) of an increased representa-
tion in the hospital barracks (unadjusted OR 4.3, 95% CI 2.1–8.4; p
< 0.001).
4. Discussion
We found the prevalence of TB, HIV, syphilis, HBV, and HCV to
be higher among male prisoners than in reports from the general
population in Pakistan, as expected.17,23,28,34 The prisoners had
low literacy rates, low socioeconomic status, and many had been
incarcerated previously, as seen in other prison studies.6,7,11
Sexual risk in these men derived from paid sex with both women
and men and with very low condom use. Substance abuse was
common (59.2%), as was needle use (23.3% of users) and needle
sharing (46% of needle users), compatible with ﬁndings from a
large Pakistan survey of drug users in 2006–2007. Infectious risk
was derived from the high proportion of drug users, their median
length of drug use (7.3 months), and the high rates of body
tattooing, piercing, use of old blades for haircuts and shaves, and
prior surgical history. (We did not study HIV-related blood
transfusion, as most men were unsure of their transfusion
history.) We saw a very high turnover of inmates, similar to
circumstances in other countries.2,11,12 Among IDUs, 84% had
been incarcerated previously, providing a vicious cycle of
acquisition and transmission both outside and inside the prison.
At the same time, these grim statistics underscore the opportu-
nity and potential community beneﬁts of screening and
treatment in a high-risk, easily-accessed population.35 The
potential danger of discharging an IDU without a community
treatment venue, an uneducated hepatitis patient, or an
untreated TB or HIV patient can extend beyond Karachi’s
metropolitan area; inmates came from all four regions of Pakistan
and nine foreign countries.
The prevalence of pulmonary TB in our study was 2.2%. This is
lower than that seen in some prison studies7–9,18,20 and about the
same as seen in a prison in India,14 though TB diagnosis deﬁnitions
differ by study. The 2.2% active TB rate is nonetheless much higher
than in the general population.17 Our deﬁnition of smear-positive
with culture conﬁrmation is more speciﬁc and less sensitive thanused by some studies. Although our study could not determine
whether or not TB was acquired in the prison, prisons are
overcrowded, may have poor ventilation, and have notoriously
poor health care facilities, including isolation rooms for active
cases. Among seven HIV-positive participants, only one was
previously diagnosed with HIV and ﬁve gave a history of injection
drug use. Syphilis prevalence (RPR-positive/TPHA-positive) was
8.9%, not the stereotypically low prevalence rate expected from a
Muslim country. A 1994 behavioral survey in Sindh prisons on
genital ulcers and urethritis concluded that STD rates would be a
serious problem in the prison population.15 There are very limited
data regarding hepatitis B and C in prison populations in
Pakistan.28 In contrast, more work has been done in Iran, which
borders Pakistan, where prison studies have focused on IDUs and
their need for harm reduction programs, especially opiate
substitution treatment.36
In our multivariable model, the signiﬁcant risk factors for any
blood-borne infection (HIV, HBV, and/or HCV) were injection drug
use and having had surgery. This suggests the origin of blood-borne
infections among IDUs and possibly during surgery due to the poor
sterilization procedures in some Pakistani venues. For syphilis,
having paid for sex with a female was the only signiﬁcant
predictor, but this might reﬂect social response bias because male-
to-male sex is not culturally acceptable in Pakistani society and is
denied, though it is prevalent.
Institutions of incarceration in both lower and upper income
countries are incubators for infectious diseases.37 This is due to the
fact that pre-incarceration prisoners are a core transmitter group
with high risk sexual behaviors such as sex work, being clients of
sexworkers, drug use including injection drug use, and low literacy
levels.38 During incarceration, prisoners may acquire new infec-
tions due to overcrowding, poor medical diagnosis and treatment,
insufﬁcient infection control, an absence of harm reduction efforts
like condom use or needle exchange, and sudden transfer to other
facilities or discharge into the community without provisions for
ongoing therapy.1 High-risk activities like tattooing, injection drug
use, and sexual activity, although banned, nonetheless take place
inside prison.37 These factors not only lead to greater vulnerability
among prisoners, but can also be a major concern for epidemics of
infectious diseases among the general population, due to the
frequent ﬂow of prisoners into the community.38
Prisons are excellent venues for screening and interrupting
infectious diseases commonly prevalent in incarcerated as well as
in general populations. Most inmates are from lower income
backgrounds and have limited access to health care services and
routine screening checkups.5 In jails and many prisons, most
inmates are incarcerated for a short period of time and if they
return to the community with undetected infections, there has
been a missed opportunity to screen and treat.39 To break this
chain of transmission in resource-limited settings, routine
screening and treatment in jails/prisons can be expected to beneﬁt
the communities to which prisoners are being released. While
proper screening and treatment in the prison is a public health
boon, conﬁdentiality of medical information of inmates who test
positive does not exist in most settings, such that news leaks into
the prison environment.37 Those with HIV, for example, are still
stigmatized and if the news leaks out that a given prisoner is HIV-
infected, he may be abused or neglected both inside and outside
the prison. If an inmate is on longer-term treatment for TB, for
example, and is transferred to another prison or released,
treatment is interrupted unless the other prison has a similar
treatment program process or there is a bridge to community-
based TB programs. Paradoxically, correction facilitiesmay provide
free shelter and food for disenfranchised, homeless persons (like
IDUs), but rarely offer harm reduction or infection screening
programs.37
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the high response rate, and our action plan to provide improved
logistic procedures for prison health care staff and improved care
for diseased prisoners. This was the ﬁrst study in Pakistan focusing
on ﬁve major infectious diseases in a prison population. Limita-
tions include our inability to assess incidence because of the cross-
sectional study design, the study of only a single facility due to
budget constraints, and the lack of IRB approval for X-ray screening
for TB (deemed more than minimal risk by the US-based IRB and
the OHRP such that a reviewwould have put our study into a >10-
month queue for special review by the US Secretary of Health and
Human Services). We had insufﬁcient numbers of events to
examine risk factors for HIV, HBV, and HCV separately. Finances
limited the extent of our workup and the number of infections that
we could diagnose. We believe improvements in clinical manage-
ment beneﬁted the study volunteers, but only a small component
of our protocol has been implemented prison-wide after comple-
tion of our study.
Pakistan spends a higher proportion of its governmental
expenditure on the military than almost any other nation,
investing comparatively little in health, education, and social
services.40 A powerful argument can be made that health,
education, and social services within a prison setting can be a
superb long-term investment. A prison-based screening program
enables early intervention among the inmates through disease
detection, treatment, and education.41 It also beneﬁts the general
population by interrupting disease transmission when detainees
return to the community, as long as bridges are built between
prison discharge and available community services, as with
directly observed therapy–short course (DOTS) for TB. Prison data
provide epidemiological insights into a subset of high-risk
populations at lower cost than comparable community surveys.39
Our results justify investing in treatable diseases such as TB, HIV
and syphilis, and they may well reﬂect conditions throughout the
nation. HBV vaccination should be provided to all inmates. HCV
prevention and care will be challenging, but health education and
rehabilitation for drug users can help, especially using opiate
agonist therapy, education, and job training. The urgency is
augmented by the marked rise in HIV seroincidence documented
among IDUs in Pakistan, surely a harbinger of worsening
conditions for a variety of opportunistic infections and STDs.
Acknowledgements
Wewould like to thank the Bridge Consultant Foundation team
for their contribution and support. Drs Suleman Otho, Rashid
Shaikh, Arshad Altaf, Raja Fahim, Ashraf Memon, Rana Muzzaffar,
Salma Batool, A. Khalique Ghauri, Timothy Sterling, JonWarkentin,
and S. Asad Ali, and Mrs. Ellen Murray, provided assistance.
Financial support: This work was supported in part by NIH
grants D43TW001035 (AIDS International Training and Research
Program), R25TW007766 (Framework Program for Global Health),
and P30AI054999 (Vanderbilt-Meharry Center for AIDS Research).
Conﬂict of interest: No conﬂict of interest to declare.
References
1. Bick JA. Infection control in jails and prisons. Clin Infect Dis 2007;45:1047–
55.
2. McIntyre AF, Studzinski A, Beidinger HA, Rabins C. STD, HIV/AIDS, and hepatitis
services in Illinois County jails. Sex Transm Dis 2009;36(2 Suppl):S37–40.
3. Walmsley R.World prison population list 2007. London: King’s College London;
2007. Available at: http://www.kcl.ac.uk/depsta/law/research/icps/downloads/
world-prison-pop-seventh.pdf. (accessed January 2010).
4. UNAIDS. 2006 Report on the global AIDS epidemics. UNAIDS 10th Anniversary
Special edition. Geneva, Switzerland: UNAIDS; 2006.
5. Niveau G. Prevention of infectious disease transmission in correctional settings:
a review. Public Health 2006;120:33–41.6. Stuckler D, Basu S, McKee M, King L. Mass incarceration can explain population
increases in TB and multidrug-resistant TB in European and central Asian
countries. Proc Natl Acad Sci U S A 2008;105:13280–5.
7. Wong MY, Leung CC, Tam CM, Kam KM, Ma CH, Au KF. TB surveillance in
correctional institutions in Hong Kong, 1999-2005. Int J Tuberc Lung Dis
2008;12:93–8.
8. Noeske J, Kuaban C, Amougou G, Piubello A, Pouillot R. Pulmonary tuberculosis
in the Central Prison of Douala, Cameroon. East Afr Med J 2006;83:25–30.
9. MacNeil JR, LobatoMN,MooreM. An unanswered health disparity: tuberculosis
among correctional inmates, 1993 through 2003. Am J Public Health 2005;95:
1800–5.
10. Verneuil L, Vidal JS, Ze Bekolo R, Vabret A, Petitjean J, Leclercq R, et al.
Prevalence and risk factors of the whole spectrum of sexually transmitted
diseases in male incoming prisoners in France. Eur J Clin Microbiol Infect Dis
2009;28:409–13.
11. Adjei AA, Armah HB, Gbagbo F, Ampofo WK, Boamah I, Adu-Gyamﬁ C, et al.
Correlates of HIV, HBV, HCV and syphilis infections among prison inmates
and ofﬁcers in Ghana: a national multicenter study. BMC Infect Dis
2008;8:33.
12. FialhoM,MessiasM, Page-Shafer K, Farre L, SchmalbM, Pedral-Sampaio D, et al.
Prevalence and risk of blood-borne and sexually transmitted viral infections in
incarcerated youth in Salvador, Brazil: opportunity and obligation for inter-
vention. AIDS Behav 2008;12(4 Suppl):S17–24.
13. Solomon L, Flynn C, Muck K, Vertefeuille J. Prevalence of HIV, syphilis, hepatitis
B, and hepatitis C among entrants to Maryland correctional facilities. J Urban
Health 2004;81:25–37.
14. Singh S, Prasad R, Mohanty A. High prevalence of sexually transmitted and
blood-borne infections amongst the inmates of a district jail in Northern India.
Int J STD AIDS 1999;10:475–8.
15. Akhtar S, Luby SP, Rahbar MH. Risk behaviours associated with urethritis in
prison inmates, Sindh. J Pak Med Assoc 1999;49:268–73.
16. Baqi S, Nabi N, Hasan SN, Khan AJ, Pasha O, Kayani N, et al. HIV antibody
seroprevalence and associated risk factors in sex workers, drug users, and
prisoners in Sindh, Pakistan. J Acquir Immune Deﬁc Syndr Hum Retrovirol
1998;18:73–9.
17. World Health Organization. Global tuberculosis control: surveillance, planning,
ﬁnancing. Geneva: WHO; 2008.
18. Rao NA. Prevalence of pulmonary tuberculosis in Karachi Central Prison. J Pak
Med Assoc 2004;54:413–5.
19. Hussain H, Akhtar S, Nanan D. Prevalence of and risk factors associated with
Mycobacterium tuberculosis infection in prisoners, North West Frontier Prov-
ince. Pakistan Int J Epidemiol 2003;32:794–9.
20. Shah SA, Mujeeb SA, Mirza A, Nabi KG, Siddiqui Q. Prevalence of pulmonary
tuberculosis in Karachi juvenile jail, Pakistan. East Mediterr Health J 2003;9:
667–74.
21. Shah SA, Altaf A, Mujeeb SA, Memon A. An outbreak of HIV infection among
injection drug users in a small town in Pakistan: potential for national implica-
tions. Int J STD AIDS 2004;15:209.
22. UNGASS indicators country report: National AIDS Control Program
Ministry of Health Government of Pakistan. Islamabad: Ministry of Health;
2006.
23. UNGASS Pakistan report: National AIDS Control Program Ministry of Health
Government of Pakistan. Islamabad: Ministry of Health; 2007.
24. Canada Pakistan HIV/AIDS Surveillance Project (CIDA); National AIDS Control
Program, Ministry of Health, Pakistan. HIV second generation surveillance in
Pakistan. National report round II, 2006-07. Islamabad: Ministry of Health;
2007.
25. Canada Pakistan HIV/AIDS Surveillance Project (CIDA); National AIDS Control
Program, Ministry of Health, Pakistan. HIV second generation surveillance in
Sindh. Round III integrated behavioral and biological surveillance report, 2008.
Islamabad: Ministry of Health; 2008.
26. Altaf A, Shah SA, Zaidi NA, Memon A, Nadeem ur R, Wray N. High risk behaviors
of injection drug users registered with harm reduction programme in Karachi.
Pakistan Harm Reduct J 2007;4:7.
27. Survey of high risk groups in Lahore and Karachi. Islamabad: National AIDS
Control Program Ministry of Health, Government of Pakistan; 2005.
28. Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in
Pakistan: prevalence and risk factors. Int J Infect Dis 2009;13:9–19.
29. Kuo I, ul-Hasan S, Galai N, Thomas DL, Zafar T, Ahmed MA, et al. High HCV
seroprevalence and HIV drug use risk behaviors among injection drug users in
Pakistan. Harm Reduct J 2006;3:26.
30. Ur-Rehman DN. Problem of drug use in Pakistan: results from year 2006
national assessment. Poster presentation at the First Asian Consultation
on the Prevention of HIV related to Drug Use, Goa, India, January 28-31,
2008.
31. The World Bank. HIV/AIDS in Pakistan, 2008. Available at: http://siteresources.
worldbank.org/INTSAREGTOPHIVAIDS/Resources/496350-1217345766462/
HIV-AIDS-brief-Aug08-PK.pdf (accessed January 2010).
32. Prison statistics for Sindh jails. Pakistan: Home Department, Government of
Sindh; 2007. Available at: http://www.sindh.gov.pk/dpt/Home/prisons.htm
(accessed January 2010).
33. Bone A, Aerts A, Grzemska M, Kimerling M, Kluge H, Levy M, et al. Tuberculosis
control in prisons: a manual for programme managers. Geneva: World Health
Organization; 2000.
34. Khan EA, Khokhar N, Malik GJ. Seroprevalence of syphilis in asymptomatic
adults seeking employment abroad. Rawal Med J 2004;29:65–7.
A.M. Kazi et al. / International Journal of Infectious Diseases 14S (2010) e60–e66e6635. Restum ZG. Public health implications of substandard correctional health care.
Am J Public Health 2005;95:1689–91.
36. Zamani S, Ichikawa S, Nassirimanesh B, Vazirian M, Ichikawa K, Gouya MM,
et al. Prevalence and correlates of hepatitis C virus infection among injecting
drug users in Tehran. Int J Drug Policy 2007;18:359–63.
37. Comfort ML, Grinstead O. The carceral limb of the public body: jail inmates,
prisoners, and infectious disease. J Int Assoc Physicians AIDS Care (Chic Ill)
2004;3:45–8.38. Clark M, Cameron DW. Health of prisoners and the public health no man is an
island J Int Assoc Physicians AIDS Care (Chic Ill) 2004;3:44.
39. White MC. Identifying infectious diseases in prisons: surveillance, protection,
and intervention. West J Med 1999;170:177.
40. Islam A, Tahir MZ. Health sector reform in South Asia: new challenges and
constraints. Health Policy 2002;60:151–69.
41. Weilandt C, Radun D. Prisons: health hazards, but also health opportunities.
Euro Surveill 2007;12(1).
